Ellipsis Ventures is a venture capital firm backing pre-seed and seed-stage companies, with a focus on AI, deep tech, enterprise software and automation. It invests in the United States, writes first checks of $250K to $1.5M, and has additional medical-device investment exposure, making it most relevant for early founders building defensible AI-driven or technical products.